PulseAugur
EN
LIVE 13:10:31

Gen Z in South Korea lead GLP-1 slimming drug use: survey

By PulseAugur Editorial · [1 sources] ·

A recent survey indicates that approximately 16.5% of South Korean Gen Z individuals used GLP-1 slimming drugs in 2025, a significantly higher rate than other age groups. The overall usage across all surveyed age brackets (25-69) was 10.3%. This trend highlights appearance as a primary driver for the adoption of these medications among younger South Koreans. AI

RANK_REASON The item discusses survey results about drug usage trends, which falls under commentary rather than a core AI release or significant industry event.

Read on SCMP — Tech →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Gen Z in South Korea lead GLP-1 slimming drug use: survey

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Commentary
The item discusses survey results about drug usage trends, which falls under commentary rather than a core AI release or significant industry event.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
Breaking (< 6h)
Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

Full methodology in our editorial standards.

COVERAGE [1]

  1. SCMP — Tech TIER_1 English(EN) · SCMP’s Asia desk ·

    1 in 6 Gen Z South Koreans took GLP-1 slimming drugs last year: survey

    South Korea’s embrace of GLP-1 weight-loss drugs appears particularly pronounced among younger adults, with roughly one in six Gen Z respondents reporting they had used or been prescribed the medication in 2025, according to a new report. The 2026 Korea Wellness Report, released …

RELATED ENTITIES

RELATED TOPICS